A study by Xiang et al. used mass cytometry to show that in patients with LSCC, there was a positive correlation between the CAF marker FAP and tumor-infiltrating immune cell (TIIC) markers, such as CD14, establishing a relationship between the presence of CAFs and their role in modulating the immune-evasive TME [4]. The gene discussed is FAP; the disease is neoplasm.